RAPP Long Call Strategy

RAPP (Rapport Therapeutics, Inc. Common Stock), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder. The company also develops RAP-199, a TARPy8 targeted molecule with differentiated chemical and pharmacokinetic properties; and nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and a9a10 nAChR for the treatment of hearing disorders. The company was formerly known as Precision Neuroscience NewCo, Inc. and changed its name to Rapport Therapeutics, Inc. in October 2022. Rapport Therapeutics, Inc. was incorporated in 2022 and is based in Boston, Massachusetts.

RAPP (Rapport Therapeutics, Inc. Common Stock) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.39B, a beta of 0.82 versus the broader market, a 52-week range of 7.73-42.269, average daily share volume of 353K, a public-listing history dating back to 2024, approximately 69 full-time employees. These structural characteristics shape how RAPP stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.82 places RAPP roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a long call on RAPP?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current RAPP snapshot

As of May 15, 2026, spot at $37.12, ATM IV 75.50%, IV rank 4.51%, expected move 21.65%. The long call on RAPP below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this long call structure on RAPP specifically: RAPP IV at 75.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a RAPP long call, with a market-implied 1-standard-deviation move of approximately 21.65% (roughly $8.03 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated RAPP expiries trade a higher absolute premium for lower per-day decay. Position sizing on RAPP should anchor to the underlying notional of $37.12 per share and to the trader's directional view on RAPP stock.

RAPP long call setup

The RAPP long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With RAPP near $37.12, the first option leg uses a $37.12 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed RAPP chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 RAPP shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$37.12N/A

RAPP long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

RAPP long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on RAPP. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on RAPP

Long calls on RAPP express a bullish thesis with defined risk; traders use them ahead of RAPP catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

RAPP thesis for this long call

The market-implied 1-standard-deviation range for RAPP extends from approximately $29.09 on the downside to $45.15 on the upside. A RAPP long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current RAPP IV rank near 4.51% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on RAPP at 75.50%. As a Healthcare name, RAPP options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to RAPP-specific events.

RAPP long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. RAPP positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move RAPP alongside the broader basket even when RAPP-specific fundamentals are unchanged. Long-premium structures like a long call on RAPP are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current RAPP chain quotes before placing a trade.

Frequently asked questions

What is a long call on RAPP?
A long call on RAPP is the long call strategy applied to RAPP (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With RAPP stock trading near $37.12, the strikes shown on this page are snapped to the nearest listed RAPP chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are RAPP long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the RAPP long call priced from the end-of-day chain at a 30-day expiry (ATM IV 75.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a RAPP long call?
The breakeven for the RAPP long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current RAPP market-implied 1-standard-deviation expected move is approximately 21.65%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on RAPP?
Long calls on RAPP express a bullish thesis with defined risk; traders use them ahead of RAPP catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current RAPP implied volatility affect this long call?
RAPP ATM IV is at 75.50% with IV rank near 4.51%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related RAPP analysis